Payment systems for dialysis and their effects: a scoping review

[1]  M. Hadian,et al.  Economic evaluation of End Stage Renal Disease treatments in Iran , 2020 .

[2]  W. Winkelmayer,et al.  Bundled Payment Reform and Dialysis Facility Closures in ESKD. , 2020, Journal of the American Society of Nephrology : JASN.

[3]  Eric R. Swenson,et al.  Economic Impact of Outpatient Medicare Total Knee Arthroplasty at a Tertiary Care Academic Medical Center. , 2020, The Journal of arthroplasty.

[4]  Aaron J. Trachtenberg,et al.  Association between change in physician remuneration and use of peritoneal dialysis: a population-based cohort analysis. , 2020, CMAJ open.

[5]  G. Anderson,et al.  Patient Selection After Mandatory Bundled Payments for Hip and Knee Replacement: Limited Evidence of Lemon-Dropping or Cherry-Picking. , 2019, The Journal of bone and joint surgery. American volume.

[6]  S. Lee,et al.  Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[7]  A. Kapke,et al.  Peritoneal Dialysis Patient Outcomes under the Medicare Expanded Dialysis Prospective Payment System. , 2019, Clinical journal of the American Society of Nephrology : CJASN.

[8]  G. Piccoli,et al.  Dialysis Reimbursement: What Impact Do Different Models Have on Clinical Choices? , 2019, Journal of clinical medicine.

[9]  B. Canaud,et al.  Chronic Kidney Disease: Exploring Value-Based Healthcare as a Potential Viable Solution , 2019, Blood Purification.

[10]  W. van Biesen,et al.  An International Analysis of Dialysis Services Reimbursement. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[11]  S. Lee,et al.  Medicare's New Prospective Payment System on Facility Provision of Peritoneal Dialysis. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[12]  J. McGowan,et al.  PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation , 2018, Annals of Internal Medicine.

[13]  S. Schneeweiss,et al.  Association of Medicare's Bundled Payment Reform With Changes in Use of Vitamin D Among Patients Receiving Maintenance Hemodialysis: An Interrupted Time-Series Analysis. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  Yi-Ting Lin,et al.  Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study , 2018, PloS one.

[15]  N. Gray,et al.  Impact of pay for performance on access at first dialysis in Queensland , 2018, Nephrology.

[16]  F. Maddux,et al.  Integrating kidney transplantation into value‐based care for people with renal failure , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  A. Ryan,et al.  Risk Adjustment May Lessen Penalties On Hospitals Treating Complex Cardiac Patients Under Medicare's Bundled Payments. , 2017, Health affairs.

[18]  Jayanta Bhattacharya,et al.  Home Dialysis in the Prospective Payment System Era. , 2017, Journal of the American Society of Nephrology : JASN.

[19]  Leonard T. Buller,et al.  Bundled Payments in Total Joint Replacement: Keeping Our Care Affordable and High in Quality , 2017, Current Reviews in Musculoskeletal Medicine.

[20]  M. Postma,et al.  Reducing the costs of chronic kidney disease while delivering quality health care: a call to action , 2017, Nature Reviews Nephrology.

[21]  W. Winkelmayer,et al.  Hemodialysis Hospitalizations and Readmissions: The Effects of Payment Reform. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  Qian Zhang,et al.  Impact of the End Stage Renal Disease Prospective Payment System on the Use of Peritoneal Dialysis , 2016, Kidney international reports.

[23]  Mark S Levenson,et al.  Association Between Changes in CMS Reimbursement Policy and Drug Labels for Erythrocyte-Stimulating Agents With Outcomes for Older Patients Undergoing Hemodialysis Covered by Fee-for-Service Medicare. , 2016, JAMA internal medicine.

[24]  J. Andrawis,et al.  Bundled payment care initiative: How this all started , 2016 .

[25]  H. Morgenstern,et al.  International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study. , 2016, Journal of the American Society of Nephrology : JASN.

[26]  W. Winkelmayer,et al.  Effects of physician payment reform on provision of home dialysis. , 2016, The American journal of managed care.

[27]  A. Collins,et al.  Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care , 2016, BMC Nephrology.

[28]  R. Myrtle,et al.  Assessing the impact of budget controls on the prescribing behaviours of physicians treating dialysis-dependent patients. , 2015, Health policy and planning.

[29]  K. Rascati,et al.  Managing oral phosphate binder medication expenditures within the Medicare bundled end-stage renal disease prospective payment system: economic implications for large U.S. dialysis organizations. , 2015, Journal of managed care & specialty pharmacy.

[30]  Vincent Mor,et al.  Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents. , 2015, Health services research.

[31]  C. Hollenbeak,et al.  Trends in prevalence of patient case-mix adjusters used in the Medicare dialysis payment system. , 2015, Nephrology news & issues.

[32]  F. Port,et al.  Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[33]  R. Rubin,et al.  Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study , 2015, BMC Nephrology.

[34]  M. Hernán,et al.  Major Declines in Epoetin Dosing after Prospective Payment System Based on Dialysis Facility Organizational Status , 2015, American Journal of Nephrology.

[35]  R. Mehrotra,et al.  The changing landscape of home dialysis in the United States , 2014, Current opinion in nephrology and hypertension.

[36]  J. Pirkle,et al.  Hemoglobin stability and patient compliance with darbepoetin alfa in peritoneal dialysis patients after the implementation of the prospective payment system. , 2014, Clinical therapeutics.

[37]  F. Port,et al.  The DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  W. Winkelmayer,et al.  Medicare Reimbursement Reform for Provider Visits and Health Outcomes in Patients on Hemodialysis , 2014, Forum for health economics & policy.

[39]  F. Port,et al.  The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  J. Wheeler,et al.  The initial impact of Medicare's new prospective payment system for kidney dialysis. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[41]  F. Port,et al.  Changes in dialysis treatment modalities during institution of flat rate reimbursement and quality assurance programs. , 2013, Kidney international.

[42]  F. Cots,et al.  Diagnosis related groups in Europe: moving towards transparency, efficiency, and quality in hospitals? , 2013, BMJ.

[43]  R. Rubin,et al.  Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS). , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[44]  Dieter Van de Craen,et al.  The importance of home and community-based settings in population health management , 2013 .

[45]  D. Marcelli,et al.  Converting to a Capitation System for Dialysis Payment – The Portuguese Experience , 2013, Blood Purification.

[46]  V. Mor,et al.  Medicare's payment strategy for end-stage renal disease now embraces bundled payment and pay-for-performance to cut costs. , 2012, Health affairs.

[47]  J. Hornberger,et al.  Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[48]  Andrew Davenport,et al.  Reimbursement of dialysis: a comparison of seven countries. , 2012, Journal of the American Society of Nephrology : JASN.

[49]  B. Gillespie,et al.  The DOPPS Practice Monitor for US dialysis care: trends through August 2011. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  D. D. de Bakker,et al.  Early results from adoption of bundled payment for diabetes care in the Netherlands show improvement in care coordination. , 2012, Health affairs.

[51]  F. Maddux.  Impact of the Bundled End-Stage Renal Disease Payment System on Patient Care , 2012, Blood Purification.

[52]  A. Webster,et al.  Comparative Survival and Economic Benefits of Deceased Donor Kidney Transplantation and Dialysis in People with Varying Ages and Co-Morbidities , 2012, PloS one.

[53]  M Susan Ridgely,et al.  The PROMETHEUS bundled payment experiment: slow start shows problems in implementing new payment models. , 2011, Health affairs.

[54]  R. Myrtle,et al.  The effect of outpatient dialysis global budget cap on healthcare utilization by end-stage renal disease patients. , 2011, Social science & medicine.

[55]  B. Gillespie,et al.  The Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor: rationale and methods for an initiative to monitor the new US bundled dialysis payment system. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[56]  S. Fukuhara,et al.  Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin. , 2011, Kidney international.

[57]  T. Golper,et al.  HOME DIALYSIS IN THE NEW USA BUNDLED PAYMENT PLAN: IMPLICATIONS AND IMPACT , 2011, Peritoneal Dialysis International.

[58]  P. McFarlane,et al.  International trends in erythropoietin use and hemoglobin levels in hemodialysis patients. , 2010, Kidney International.

[59]  T. Mayne,et al.  Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[60]  K. Fushimi,et al.  The impact of a new payment system with case-mix measurement on hospital practices for breast cancer patients in Japan. , 2009, Health policy.

[61]  M. Solomon,et al.  Is there "cherry picking" in the ESRD Program? Perceptions from a Dialysis Provider Survey. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[62]  J. Wish.  Past, present, and future of chronic kidney disease anemia management in the United States. , 2009, Advances in chronic kidney disease.

[63]  F. D. de Charro,et al.  Reimbursement and economic factors influencing dialysis modality choice around the world , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[64]  A. Harris.  The organization and funding of the treatment of end-stage renal disease in Australia , 2007, International Journal of Health Care Finance and Economics.

[65]  W. Kleophas,et al.  International study of health care organization and financing: development of renal replacement therapy in Germany , 2007, International Journal of Health Care Finance and Economics.

[66]  S. Fukuhara,et al.  The organization and financing of end-stage renal disease treatment in Japan , 2007, International Journal of Health Care Finance and Economics.

[67]  I. Durand-zaleski,et al.  International Study of Health Care Organization and Financing for end-stage renal disease in France , 2007, International Journal of Health Care Finance and Economics.

[68]  S. Jacobson,et al.  The financing and organization of medical care for patients with end-stage renal disease in Sweden , 2007, International Journal of Health Care Finance and Economics.

[69]  P. Roderick,et al.  International Study of Health Care Organization and Financing of renal services in England and Wales , 2007, International Journal of Health Care Finance and Economics.

[70]  F. Locatelli,et al.  International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality , 2007, International Journal of Health Care Finance and Economics.

[71]  R. Vanholder,et al.  Belgium’s mixed private/public health care system and its impact on the cost of end-stage renal disease , 2007, International Journal of Health Care Finance and Economics.

[72]  B. Manns,et al.  The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care , 2007, International Journal of Health Care Finance and Economics.

[73]  M. Marshall,et al.  The organization and financing of dialysis and kidney transplantation services in New Zealand , 2007, International Journal of Health Care Finance and Economics.

[74]  J. Luño.  The organization and financing of end-stage renal disease in Spain , 2007, International Journal of Health Care Finance and Economics.

[75]  R. Hirth,et al.  The organization and financing of kidney dialysis and transplant care in the United States of America , 2007, International Journal of Health Care Finance and Economics.

[76]  M. Pauly,et al.  End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF) , 2007, International Journal of Health Care Finance and Economics.

[77]  A. Ghods,et al.  Iranian model of paid and regulated living-unrelated kidney donation. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[78]  H. Naito.  The Japanese Health-Care System and Reimbursement for Dialysis , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[79]  A. Sehgal,et al.  Changes in Medicare reimbursement and patient-nephrologist visits, quality of care, and health-related quality of life. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[80]  H. Arksey,et al.  Scoping studies: towards a methodological framework , 2005 .

[81]  P. Blake,et al.  Peritoneal Dialysis in Ontario: A Natural Experiment in Physician Reimbursement Methodology , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[82]  T. Mettang.  Changes in Dialysis Reimbursement Regulations in Germany , 2004, Peritoneal Dialysis International.

[83]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..